Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	5.93	6.75	11.63	19.76	0.8	0.08
Cash & Cash Equivalents	5.93	6.75	11.63	19.76	0.8	0.08
Cash Growth	-38.66%	-41.97%	-41.15%	2370.22%	900.02%	-
Receivables	0.54	0	0.04	0	0	0
Other Current Assets	0.03	0.06	0.28	0.28	0.08	0
Total Current Assets	6.5	6.81	11.95	20.04	0.88	0.08
Property, Plant & Equipment	0.03	0.07	0.14	0	0	0
Goodwill and Intangibles	0	0	0	0	0	0
Total Long-Term Assets	0.03	0.07	0.14	0	0	0
Total Assets	6.53	6.88	12.09	20.04	0.88	0.08
Accounts Payable	0.81	0.21	1.4	0.64	0.15	0.04
Other Current Liabilities	0.03	0.07	0.07	0	0	0
Total Current Liabilities	0.85	0.28	1.47	0.64	0.15	0.04
Long-Term Debt	0	0	0.07	0	0	0
Total Long-Term Liabilities	0	0	0.07	0	0	0
Total Liabilities	0.85	0.28	1.54	0.64	0.15	0.04
Total Debt	0	0	0.07	0	0	0
Retained Earnings	-33.81	-31.55	-24.17	-9.21	-0.56	-0.08
Shareholders' Equity	5.69	6.6	10.54	19.4	0.73	0.05
Net Cash / Debt	5.93	6.75	11.56	19.76	0.8	0.08
Net Cash / Debt Growth	-38.44%	-41.61%	-41.52%	2370.22%	900.02%	-
Net Cash Per Share	1.33	1.81	4.68	11.01	1.11	0.19
Working Capital	5.66	6.53	10.48	19.4	0.73	0.04
Book Value Per Share	1.27	1.77	4.27	10.81	1.01	0.11

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).